TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $15,000 | -87.7% | 13,429 | -69.8% | 0.00% | – |
| Q3 2018 | $122,000 | +29.8% | 44,406 | +44.1% | 0.00% | -100.0% |
| Q1 2018 | $94,000 | -56.7% | 30,813 | -10.9% | 0.00% | -55.6% |
| Q4 2017 | $217,000 | +3000.0% | 34,596 | +1842.5% | 0.01% | – |
| Q4 2016 | $7,000 | -41.7% | 1,781 | -38.8% | 0.00% | -100.0% |
| Q2 2016 | $12,000 | -80.6% | 2,912 | -78.5% | 0.00% | -80.0% |
| Q1 2016 | $62,000 | -90.0% | 13,570 | -83.7% | 0.01% | -88.9% |
| Q3 2015 | $620,000 | +49.0% | 83,235 | +849.2% | 0.04% | +28.6% |
| Q2 2015 | $416,000 | +150.6% | 8,769 | +93.5% | 0.04% | +84.2% |
| Q1 2015 | $166,000 | -7.8% | 4,532 | +0.1% | 0.02% | -13.6% |
| Q4 2014 | $180,000 | – | 4,529 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |